Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.043 1 day ( 0 % )
Last Price $4.34 -3.77 %
High/ Low $4.31 - $4.55 6.03%
Chg 7 Days -0.91 % $4.38 $4.34
Chg 30 Days -14.57 % $5.08 $4.34
Chg 12 mos 42.76 % $3.04 $4.34
Trend - 3 mos -18.91 % Width: 88.03 %
Trend - 12 mos 52.56 % Width: 179.82 %
Pred. range - 3 mos $2.40 - $4.51 -44.71 % - 3.96 %
Pred. range - 12 mos $3.85 - $10.78 -11.24 % - 148.35 %
Short MA avg 3 mos Buy May 08, 2024 - 3 days
Long MA avg 3 mos Sell Apr 09, 2024 - 24 days
Short/Long MA avg 3 mos Sell Apr 11, 2024 - 22 days
Short MA avg 12 mos Sell Apr 12, 2024 - 21 days
Long MA avg 12 mos Buy Dec 29, 2023 - 92 days
Short/Long MA avg 12 mos Buy Jan 09, 2024 - 86 days
Pivot Short Sell Apr 19, 2024 - 16 days
Bollinger Buy Dec 06, 2023 - 108 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Pyxis Oncology, Inc.

Pyxis Oncology. Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therap... PYXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT